A new meta-analysis of more than 6000 studies shows that oral contraceptives significantly reduce the risk of ovarian cancer. The risk reduction increases proportionally with duration of use.
See the abstract here
Related Topics
Action Alert: Urge Congress to Pass Final Bill on Cancer Research Funding and Early Detection
The Congressional Appropriations Committees have released a combined FY2026 Defense/Labor, Health and Human Services bill—and it includes several critical investments and policy provisions that would significantly strengthen the federal response to ovarian and other gynecologic cancers. This bill represents meaningful progress for our community, but it is not final. Congress must act swiftly to advance and … Continued
OCRA Urges Immediate Passage of Bill Supporting Ovarian Cancer Research, Education, and Early Detection
The Ovarian Cancer Research Alliance today praised the release of the FY2026 Labor, Health and Human Services, Education, and Related Agencies appropriations bill by the Congressional Appropriations Committees and urged swift action to advance and enact the legislation. The bill includes critical funding and policy provisions supporting ovarian cancer research, education, and early detection. Add Your Voice … Continued
OCRA VP of Policy Featured in Citybiz on Launch of New Center for Public Policy
In a new piece published by citybiz, OCRA’s Vice President, Policy, Chad Ramsey, discusses the launch of OCRA’s Center for Public Policy, highlighting its role in expanding critical advocacy work and bringing more agency to the gynecologic cancer community. Ramsey explains how patient, survivor, and caregiver experiences have helped shape OCRA’s advocacy priorities over the past … Continued